UNSPSC 85814303: Introduction of embryonic stem cells into spinal canal, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of embryonic stem cells into spinal canal, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0R0AZ

UNSPSC 85814303 Introduction of embryonic stem cells into spinal canal, open approach is a Commodity code that nominally describes a surgical neurological intervention, yet the recent state and local opportunities posted under this code show little activity directly aligned with that clinical scope. The three recent opportunities tagged to this code—Inland Empire Health Plan's Request for Information (RFI) on 24/7 virtual urgent care services (due October 31, 2026), DeKalb County's medical services procurement (due November 12, 2026), and the Nevada Health Authority's Program of All Inclusive Care for the Elderly (PACE) RFP (due December 10, 2026)—encompass telehealth urgent care delivery, unspecified general medical services, and comprehensive senior care management respectively. None of these solicitations reference embryonic stem cell therapy, spinal canal procedures, or open surgical approaches. The code's nominal designation and the actual content of recent procurement activity diverge significantly, suggesting either a data taxonomy classification error or that state and local procurement systems have applied this code to broader health service categories without precision alignment to its intended Commodity definition.

The issuing bodies represent typical state and local health authority structures: a county health plan serving a regional population (IEHP in California's San Bernardino County), a county government (DeKalb County, Georgia), and a state health authority operating statewide programs (Nevada Health Authority). Geographic activity centers on California, Georgia, and Nevada. Without recent solicitations that genuinely reflect stem cell or advanced spinal intervention procurement, this code warrants low pursuit priority for vendors specializing in cellular therapeutics, neurosurgical services, or transplant infrastructure. Firms offering telehealth platforms, primary care services, or senior care programming may monitor this code for future clarification or reclassification, though the current mismatch between code definition and actual buying activity limits forward-looking visibility.